136 related articles for article (PubMed ID: 38375688)
1. Exosomal miR-93 derived from hepatocellular carcinoma cell promotes the sorafenib resistance of hepatocellular carcinoma through PTEN/PI3K/Akt pathway.
Bao Y; Xu S; Zhou J; Zhao C; Dai S; Zhang Y; Rao M
J Biochem Mol Toxicol; 2024 Mar; 38(3):e23666. PubMed ID: 38375688
[TBL] [Abstract][Full Text] [Related]
2. Exosomal microRNA-32-5p induces multidrug resistance in hepatocellular carcinoma via the PI3K/Akt pathway.
Fu X; Liu M; Qu S; Ma J; Zhang Y; Shi T; Wen H; Yang Y; Wang S; Wang J; Nan K; Yao Y; Tian T
J Exp Clin Cancer Res; 2018 Mar; 37(1):52. PubMed ID: 29530052
[TBL] [Abstract][Full Text] [Related]
3. Circular RNA ITCH increases sorafenib-sensitivity in hepatocellular carcinoma via sequestering miR-20b-5p and modulating the downstream PTEN-PI3K/Akt pathway.
Li X; Yin X; Bao H; Liu C
Mol Cell Probes; 2023 Feb; 67():101877. PubMed ID: 36442661
[TBL] [Abstract][Full Text] [Related]
4. Exosome-Mediated MiR-155 Transfer Contributes to Hepatocellular Carcinoma Cell Proliferation by Targeting PTEN.
Sun JF; Zhang D; Gao CJ; Zhang YW; Dai QS
Med Sci Monit Basic Res; 2019 Oct; 25():218-228. PubMed ID: 31645540
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway.
Fu X; Wen H; Jing L; Yang Y; Wang W; Liang X; Nan K; Yao Y; Tian T
Cancer Sci; 2017 Apr; 108(4):620-631. PubMed ID: 28132399
[TBL] [Abstract][Full Text] [Related]
6. Exosomal MiR-744 Inhibits Proliferation and Sorafenib Chemoresistance in Hepatocellular Carcinoma by Targeting PAX2.
Wang G; Zhao W; Wang H; Qiu G; Jiang Z; Wei G; Li X
Med Sci Monit; 2019 Sep; 25():7209-7217. PubMed ID: 31553714
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-92b augments sorafenib resistance in hepatocellular carcinoma via targeting PTEN to activate PI3K/AKT/mTOR signaling.
Cheng Z; Ni Q; Qin L; Shi Y
Braz J Med Biol Res; 2021; 54(9):e10390. PubMed ID: 34076140
[TBL] [Abstract][Full Text] [Related]
8. MiR-21 mediates sorafenib resistance of hepatocellular carcinoma cells by inhibiting autophagy via the PTEN/Akt pathway.
He C; Dong X; Zhai B; Jiang X; Dong D; Li B; Jiang H; Xu S; Sun X
Oncotarget; 2015 Oct; 6(30):28867-81. PubMed ID: 26311740
[TBL] [Abstract][Full Text] [Related]
9. High-metastatic cancer cells derived exosomal miR92a-3p promotes epithelial-mesenchymal transition and metastasis of low-metastatic cancer cells by regulating PTEN/Akt pathway in hepatocellular carcinoma.
Yang B; Feng X; Liu H; Tong R; Wu J; Li C; Yu H; Chen Y; Cheng Q; Chen J; Cai X; Wu W; Lu Y; Hu J; Liang K; Lv Z; Wu J; Zheng S
Oncogene; 2020 Oct; 39(42):6529-6543. PubMed ID: 32917956
[TBL] [Abstract][Full Text] [Related]
10. LncRNA SNHG1 contributes to sorafenib resistance by activating the Akt pathway and is positively regulated by miR-21 in hepatocellular carcinoma cells.
Li W; Dong X; He C; Tan G; Li Z; Zhai B; Feng J; Jiang X; Liu C; Jiang H; Sun X
J Exp Clin Cancer Res; 2019 May; 38(1):183. PubMed ID: 31053148
[TBL] [Abstract][Full Text] [Related]
11. miR-218 modulate hepatocellular carcinoma cell proliferation through PTEN/AKT/PI3K pathway and HoxA10.
Xiao ZD; Jiao CY; Huang HT; He LJ; Zhao JJ; Lu ZY; Liu LX
Int J Clin Exp Pathol; 2014; 7(7):4039-44. PubMed ID: 25120782
[TBL] [Abstract][Full Text] [Related]
12. MiR-128-3p overexpression sensitizes hepatocellular carcinoma cells to sorafenib induced apoptosis through regulating DJ-1.
Guo XL; Wang HB; Yong JK; Zhong J; Li QH
Eur Rev Med Pharmacol Sci; 2018 Oct; 22(20):6667-6677. PubMed ID: 30402839
[TBL] [Abstract][Full Text] [Related]
13. Circ_0004018 suppresses cell proliferation and migration in hepatocellular carcinoma via miR-1197/PTEN/PI3K/AKT signaling pathway.
Wang H; Zhang Q; Cui W; Li W; Zhang J
Cell Cycle; 2021 Oct; 20(20):2125-2136. PubMed ID: 34570663
[TBL] [Abstract][Full Text] [Related]
14. miR-382-5p promotes cell invasion in hepatocellular carcinoma by targeting PTEN to activate PI3K/Akt signaling pathway.
Lv B; Liu X; Zhu X; Huang M
World J Surg Oncol; 2022 Jun; 20(1):175. PubMed ID: 35655254
[TBL] [Abstract][Full Text] [Related]
15. Hepatocellular carcinoma-derived exosomal miRNA-21 contributes to tumor progression by converting hepatocyte stellate cells to cancer-associated fibroblasts.
Zhou Y; Ren H; Dai B; Li J; Shang L; Huang J; Shi X
J Exp Clin Cancer Res; 2018 Dec; 37(1):324. PubMed ID: 30591064
[TBL] [Abstract][Full Text] [Related]
16. KDM5B regulates the PTEN/PI3K/Akt pathway to increase sorafenib-resistance in hepatocellular carcinoma.
Liu J; Nie C
Anticancer Drugs; 2022 Oct; 33(9):840-849. PubMed ID: 35946516
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-93 activates c-Met/PI3K/Akt pathway activity in hepatocellular carcinoma by directly inhibiting PTEN and CDKN1A.
Ohta K; Hoshino H; Wang J; Ono S; Iida Y; Hata K; Huang SK; Colquhoun S; Hoon DS
Oncotarget; 2015 Feb; 6(5):3211-24. PubMed ID: 25633810
[TBL] [Abstract][Full Text] [Related]
18. AEG-1/miR-221 Axis Cooperatively Regulates the Progression of Hepatocellular Carcinoma by Targeting PTEN/PI3K/AKT Signaling Pathway.
Kannan M; Jayamohan S; Moorthy RK; Chabattula SC; Ganeshan M; Arockiam AJV
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31698701
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of microRNA-30a-5p inhibits liver cancer cell proliferation and induces apoptosis by targeting MTDH/PTEN/AKT pathway.
Li WF; Dai H; Ou Q; Zuo GQ; Liu CA
Tumour Biol; 2016 May; 37(5):5885-95. PubMed ID: 26589417
[TBL] [Abstract][Full Text] [Related]
20. Extracellular vesicles derived from cancer-associated fibroblasts carry tumor-promotive microRNA-1228-3p to enhance the resistance of hepatocellular carcinoma cells to sorafenib.
Zhang Y; Pan Q; Shao Z
Hum Cell; 2023 Jan; 36(1):296-311. PubMed ID: 36424471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
